Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KitazatoTSE:368A +0.79%22 PS Ratio is 5.12 as of Jul. 31, 2026, which is 9% below its 10-year median of 5.64. GuruFocus rates TSE:368A with a GF Score™ of 22/100. Among 803 Medical Devices & Instruments companies, Kitazato ranks worse than 69.99% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Kitazato's share price is 円1401.00.
Kitazato's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円273.68. Hence, Kitazato's PS Ratio for today is 5.12.
The historical rank and industry rank for Kitazato's PS Ratio or its related term are showing as below:
TSE:368A'
s PS Ratio Range Over the Past 10 Years
Min: 4.3 Med: 5.64 Max: 7.3
Current: 5.11
During the past 4 years, Kitazato's highest PS Ratio was 7.30. The lowest was 4.30. And the median was 5.64.
TSE:368A's PS Ratio is ranked worse than 69.99% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.91
vs TSE:368A: 5.11
Kitazato's Revenue per Sharefor the
six
months ended in Mar. 2026 was 円142.50.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円273.68.
During the past 12 months, the average Revenue per Share Growth Rate of Kitazato was 6.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.40% per year.
During the past 4 years, Kitazato's highest 3-Year average Revenue per Share Growth Rate was 5.40% per year. The lowest was 5.40% per year. And the median was 5.40% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Kitazato PS Ratio Related Terms
Kitazato PS Ratio Historical Data
* Premium members only.
The historical data trend for Kitazato's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Kitazato's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kitazato PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kitazato's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kitazato's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Kitazato's Share Price of today is 円1401.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kitazato's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円273.68.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Kitazato (TSE:368A) has a PS Ratio of 5.12 as of Jul. 31, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kitazato and its competitors. This is near median its historical median of 5.64. Over the past decade, Kitazato's PS Ratio has ranged from 4.30 to 7.30. According to the industry distribution chart, Kitazato ranks #562 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 70%.
Is Kitazato's PS Ratio too high?
Kitazato's current PS Ratio of 5.12 is near median its 10-year median of 5.64. Over the past 10 years, this metric has ranged from a low of 4.30 to a high of 7.30. The Medical Devices & Instruments industry median PS Ratio is 2.91. Kitazato's value of 5.12 is 75.9% above this industry median. Based on the distribution chart, Kitazato ranks #562 out of 803 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Kitazato has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Kitazato's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kitazato ranks #562 out of 803 companies for PS Ratio. This places Kitazato in the lower half of its industry. The industry median PS Ratio is 2.91. Kitazato's value of 5.12 is 75.9% above this benchmark. Historically, Kitazato's own PS Ratio has ranged from 4.30 to 7.30 over the past decade. While the company's 10-year median is 5.64 vs. the industry median of 2.91, Kitazato has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.91, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kitazato's current PS Ratio of 5.12 is 75.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kitazato and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kitazato's current PS Ratio is 5.12, which is near median its own 10-year median of 5.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kitazato stock overvalued right now?
Kitazato (TSE:368A) has a current PS Ratio of 5.12. The current PS Ratio is 5.12, which is near median its 10-year median of 5.64 and 75.9% above the Medical Devices & Instruments industry median of 2.91. Kitazato's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Kitazato (TSE:368A), the current PS Ratio is 5.12 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kitazato Corp is engaged in manufacture and sale of medical devices and related products for fertility treatment. Its products include Needles, Catheters and Cannulas, Vitrification Media and Equipments, Sperm Processing Medium/Tools, IVF Medium, etc.
22GF Score
Get the complete analysis for TSE:368A
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:368A has been successfully added to your 
